Padua prediction score or clinical judgment for decision making on antithrombotic prophylaxis: a quasi-randomized controlled trial-Reference-Cited by-同舟云学术

Padua prediction score or clinical judgment for decision making on antithrombotic prophylaxis: a quasi-randomized controlled trial

Published:2016-04-06 Issue:3 Volume:42 Page:336-339
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Germini Federico,Agnelli Giancarlo,Fedele Marta,Galli Maria Giulia,Giustozzi Michela,Marcucci Maura,Paganelli Gloria,Pinotti Emanuele,Becattini Cecilia

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-016-1358-z.pdf

Reference5 articles.

1. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O’Fallon WM, Melton LJ 3rd (2000) Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 160:761–768

2. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H, Schulman S, Murad MH, American College of Chest P (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e195S–e226S. doi: 10.1378/chest.11-2296

3. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 8:2450–2457. doi: 10.1111/j.1538-7836.2010.04044.x

4. Schulman S, Kearon C, the SOCOAOTS, Standardization Committee Of The International Society On T, Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J thromb haemost 3(4):692–694. doi: 10.1111/j.1538-7836.2005.01204.x

5. van Gogh I, Buller HR, Cohen AT, Davidson B, Decousus H, Gallus AS, Gent M, Pillion G, Piovella F, Prins MH, Raskob GE (2007) Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med 357:1094–1104

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of a pulmonary embolism risk assessment model in gynecological inpatients;Thrombosis Journal;2024-06-05

2. Prophylaxis of venous thromboembolism during hospitalization in Internal Medicine: a subanalysis of the FADOI-NoTEVole study.;2024-05-29

3. An Electronic Medical Record Intervention to Increase Pharmacologic Prophylaxis for Venous Thromboembolism in Emergency Department Observation Patients;Annals of Emergency Medicine;2024-01

4. Risk Scores in Venous Thromboembolism Guidelines of ESC, ACCP, and ASH: An Updated Review;Clinical and Applied Thrombosis/Hemostasis;2024-01

5. Metabolic Blood Hormones in Young People With Electrocardiographic Signs of Ischemic Myocardial Changes;Kardiologiia;2023-12-05